1999, Number 4
<< Back Next >>
Rev Mex Patol Clin Med Lab 1999; 46 (4)
Toxins of Vibrio cholerae. A review
Robles ELA, García ERM, Torres LJ
Language: Spanish
References: 11
Page: 255-259
PDF size: 79.87 Kb.
ABSTRACT
Objective: Analize the mechanisms of action of Vibrio cholerae and report some pathophysiological aspects with emphasis in its toxins.
Material and methods: Review of literature years 1992-1997.
REFERENCES
Albert MJ. Vibrio cholerae 0139 Bengal. J Clin Microbiol 1994 ; 32: 2345-2349.
Manning PA. Microblogy and inmunology. The University of Adelaide 1996.
Bhadra RK, Roychoudhury S et al. Cholera toxin (ctx) genetic element in Vibrio cholerae 0139. Microbiol 1996; 141: 1977-83.
Echeverria P, Hoge ChW et al. Molecular characterization of Vibrio cholerae 0139 isolate from Asia. Am J Trop Med Hyg 1995; 52(2): 124-127.
Otterman KM, Mekalanos JJ. The ToxR Protein of Vibrio cholerae forms hemodimers and heterodimers. J of Bacterial 1996; 178: 156-162.
Coster TS, Killeen KP et al. Safety inmunogenicity and efficacy of live attenuated Vibro cholerae 0139 vaccine prototype. The Lancet 1995; 345: 949-952.
Waldor MK, Mekalanos JJ. Emergence of a new cholera pandemic: Molecular analysis of virulence determinants in Vibrio cholerae 0139 and deplopment of a live vaccine prototype. J Infec Dis 1994; 170: 278-83.
Manning PA, Straeher VH. American Society for Microbilogy Washington, 1995.
Yamamoto TM, Albert J, Sach RB. Adherence to the human small intestines of capsulated Vibrio cholerae 0139. Microbiol 1997; 119: 229-236.
Weintraub AG, Wildman PE et al. Vibrio cholerae 0139 bengal possesses a capsular polysaccharides which may confer increased virulence. Microbiol Patholog 1994; 16: 235-241.
Gardel CL, Mekalanos JJ. Regulation of cholera toxin by temperature, pH and osmolarity. Methods in enzimology 1997; 25 517-521.